Welcome to our dedicated page for Owens & Minor news (Ticker: OMI), a resource for investors and traders seeking the latest updates and insights on Owens & Minor stock.
Owens & Minor, Inc. (NYSE: OMI) is a prominent healthcare logistics company specializing in the distribution and logistics of medical products. The company plays a crucial role in ensuring the seamless delivery of vital medical supplies from manufacturers to healthcare providers. With a presence in both the United States and Europe, Owens & Minor operates strategically positioned logistics platforms that serve markets responsible for three-quarters of global healthcare spending.
Headquartered in Richmond, Virginia, this Fortune 500 company boasts annualized revenues exceeding $9 billion. Owens & Minor's diverse customer base includes independent hospitals, large integrated healthcare networks, group purchasing organizations, healthcare product manufacturers, and the federal government.
Owens & Minor operates under two main segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment focuses on the manufacturing and sourcing of medical-surgical products. This segment also provides solutions to prevent healthcare-associated infections across various healthcare settings. On the other hand, the Patient Direct segment delivers disposable medical supplies directly to patients and home health agencies, enhancing the accessibility of essential healthcare products.
Recent achievements include strategic partnerships to expand their reach and optimize their supply chain operations. These initiatives aim to enhance service efficiency, ensuring that patients receive necessary medical supplies promptly and healthcare providers can focus on delivering quality care.
Owens & Minor's unwavering commitment to innovation and quality has positioned it as a leader in healthcare logistics. For more detailed information, visit their official website.
Owens & Minor (NYSE: OMI) has announced its acquisition of Apria (NASDAQ: APR) at $37.50 per share, totaling approximately $1.45 billion in equity and $1.6 billion including assumed debt. This strategic move aims to enhance healthcare services from hospital to home, diversify revenue streams, and strengthen its Patient Direct offering. The deal, providing a premium of 26-30% over Apria’s recent share prices, is expected to close in H1 2022, pending regulatory approvals. Both companies anticipate significant synergies, positioning Owens & Minor for future growth in the $50 billion home healthcare market.
Owens & Minor, Inc. (NYSE: OMI) reports on the progress of the Owens & Minor Foundation since its launch in June 2021, emphasizing its commitment to healthcare, environment, and diversity and inclusion. The organization has supported various charitable groups, including the Boys & Girls Clubs of Metro Atlanta and St. Jude Children's Research Hospital. Shana C. Neal, EVP and Chief Human Resources Officer, highlights the importance of community engagement in achieving the foundation's goals. The foundation will focus on social determinants of health in 2022.
Owens & Minor, Inc. recognized leaders in diversity and inclusion at the 2021 Earl G. Reubel Awards, held virtually on December 16. The awards, established in partnership with Kerma Medical Products and the Healthcare Supplier Diversity Alliance, honored individuals and organizations across three categories: Civic Leadership, Diverse Enterprise, and Large Corporation. Deborah Williams, SDVOSB Laboratory, and Premier, Inc. were among the key awardees. Edward A. Pesicka, CEO, emphasized that these winners reflect a commitment to supplier diversity, critical for advancing healthcare.
Owens & Minor, Inc. (NYSE: OMI) has announced that Andy Long, Executive Vice President & Chief Financial Officer, will present at the Bank of America Securities Leveraged Finance Conference on November 30, 2021, at 3:45 PM EST. A live webcast and replay of the presentation will be accessible via the Investor Relations section of the Owens & Minor website. The company is a leading global healthcare solutions provider, serving over 4,000 customers with a workforce of more than 15,000 individuals, primarily based in the Americas.
Owens & Minor has launched its new consumer brand, SAFESKIN*, featuring task-focused Nitrile Gloves sold in POP-N-GO* packs. These packs are designed for convenience, allowing users to prepare for various tasks while ensuring protection from germs and chemicals. The gloves come in different levels of protection and are color-coded for easy selection. The launch responds to increased consumer demand for reliable protective gear, with data indicating a significant uptick in glove usage across various sectors.
Owens & Minor announced that board members Aster Angagaw and retired Lt. Gen. Gwendolyn Bingham were included in Savoy Magazine's list of 2021 Most Influential Black Corporate Directors. This recognition underscores the company's commitment to diversity and highlights the extensive leadership experience these directors bring. Bingham's military background and Angagaw’s experience in growth and transformation are seen as vital assets for Owens & Minor's mission to advance healthcare.
Owens & Minor (NYSE-OMI) reported a strong Q3 2021, showing over 14% year-over-year revenue growth at $2.502 billion. Adjusted net income reached $56 million, with EPS of $0.74. The company achieved operating income of $79.3 million, despite inflation pressures. They narrowed 2021 guidance, expecting adjusted EPS between $3.90 and $4.10 and adjusted EBITDA of $475 million to $500 million. Ongoing growth in Global Solutions and Global Products segments has contributed to a strengthened financial position.
Owens & Minor, Inc. (NYSE: OMI) has announced a dividend payment of $0.0025 per share for the fourth quarter of 2021. This payment will be made on December 31, 2021, to shareholders of record as of December 15, 2021. The company, based in Richmond, Virginia, provides healthcare solutions and has been operational since 1882, serving over 4,000 customers globally with a workforce of more than 15,000.
Owens & Minor, Inc. (NYSE: OMI) is set to release its third quarter 2021 financial results on November 3, 2021, before the market opens. A conference call to discuss these results will be held at 8:30 a.m. EDT on the same day. Interested participants can dial in at 866-393-1604 or 1-224-357-2191 internationally. The call will also be accessible via a webcast on the company's website. Owens & Minor is a global healthcare solutions provider, serving over 4,000 healthcare customers with a focus on product manufacturing and distribution.
FAQ
What is the current stock price of Owens & Minor (OMI)?
What is the market cap of Owens & Minor (OMI)?
What does Owens & Minor, Inc. do?
Where is Owens & Minor headquartered?
What are the main segments of Owens & Minor's business?
Who are Owens & Minor's customers?
How much revenue does Owens & Minor generate annually?
What regions do Owens & Minor serve?
What recent achievements has Owens & Minor accomplished?
What is the focus of the Products & Healthcare Services segment?
What does the Patient Direct segment do?